Invibio are pleased to announce that they, alongside the University of Leeds’s School of Mechanical Engineering and a consortium of other academic and industrial collaborators, have been successful in securing a grant worth nearly £1.7 million from the UK’s Engineering and Physical Sciences Research Council (EPSRC). This will be used to progress key research that aims to improve patient outcomes in primary total knee arthroplasty (TKA) procedures.
The project will focus on the Invibio PEEK-OPTIMA™ femoral knee component, which is currently in clinical trial and showing encouraging results and will investigate alternative ways to fix the knee replacement into bone, along with how the natural tissue of the knee-cap interacts with the polymer.
Dr John Devine, Managing Director at Invibio said: “We are delighted to be working with Leeds University and others and to have secured this funding, which will boost our own significant investment into research and clinical trials from our New Product Development Centre in Leeds. Our PEEK-OPTIMA™ femoral knee component is already showing encouraging results in implanted patients during trials which has the potential to improve patient outcomes and their experience.”
Dr Andrew Bourne, Director of Partnerships at EPSRC said the “Prosperity Partnerships” programme, which encompasses the grant for Prof Jennings and Invibio, shows how business and academia can work together and deliver economic and societal impact.”
He added: “These new projects showcase the breadth of research and innovation in the UK, covering a wider range of sectors, and support the UK’s ambitions to be a science superpower and an innovation nation.”
Click here to find out more about the Invibio PEEK-OPTIMA™ femoral knee component
You may also be interested in...
